Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
196.58
-2.09 (-1.05%)
At close: Jun 18, 2026, 4:00 PM EDT
196.45
-0.13 (-0.07%)
After-hours: Jun 18, 2026, 7:00 PM EDT

Biogen Stock Forecast

Stock Price Forecast

According to 36 analysts polled by S&P Global, Biogen stock has a consensus rating of "Buy" and an average price target of $220.25. The average 1-year stock price forecast is 12.04% higher than the current stock price, while the lowest is $150 (-23.70%) and the highest is $300 (+52.61%).

Price Target: $220.25 (+12.04%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$150$220.25$220$300
Change-23.70%+12.04%+11.91%+52.61%

Analyst Ratings

The average analyst rating for Biogen stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy141414171818
Buy211223
Hold182020161514
Sell000000
Strong Sell111111
Total353636363636

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Needham
Needham
Buy
Reiterates
$255
BuyReiterates$255+29.72%Jun 18, 2026
Morgan Stanley
Morgan Stanley
Hold
Reiterates
$206$224
HoldReiterates$206$224+13.95%Jun 18, 2026
BMO Capital
BMO Capital
Hold
Maintains
$196
HoldMaintains$196-0.30%Jun 18, 2026
Mizuho Securities
Mizuho Securities
Buy
Reiterates
$236$221
BuyReiterates$236$221+12.42%Jun 12, 2026
Piper Sandler
Piper Sandler
Buy
Reiterates
$225
BuyReiterates$225+14.46%May 29, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
10.05B
from 9.89B
Increased by 1.64%
Revenue Next Year
10.38B
from 10.05B
Increased by 3.27%
EPS This Year
13.32
from 15.28
Decreased by -12.80%
EPS Next Year
16.62
from 13.32
Increased by 24.77%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
10.98B10.17B9.84B9.68B9.89B10.05B
Revenue Growth
-18.32%-7.36%-3.32%-1.62%2.22%1.64%
Gross Profit
8.87B7.90B7.30B7.55B7.81B7.81B
Gross Margin
80.79%77.61%74.24%78.00%78.95%77.66%
Operating Income
3.44B3.02B1.90B2.61B2.85B2.81B
Net Income
1.56B3.05B1.16B1.63B1.29B1.18B
EPS
----15.2813.32
EPS Growth
-----7.23%-12.80%
Forward PE
13.9417.7017.549.7113.6614.75
Free Cash Flow
2.21B1.39B981.44M3.45B1.95B2.67B
No. Analysts
-----23
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High10.3B
Avg10.1B
Low9.6B

Revenue Growth

Revenue Growth202620272028
High
4.6%
Avg
1.6%
Low
-3.1%

EPS Forecast

EPS202620272028
High15.90
Avg13.32
Low-10.65

EPS Growth

EPS Growth202620272028
High
4.1%
Avg
-12.8%
Low-